Free Content von Willebrand factor type D domain mutant of SVS-1/SUSD2, vWDm, induces apoptosis in HeLa cells

Authors: Sugahara, Tetsuo1; Yamashita, Yzumi1; Shinomi, Masahito1; Isobe, Yumiko1; Yamanoha, Banri2; Iseki, Hiroyoshi3; Takeda, Akihiko3; Okazaki, Yasushi; Kawai, Kenji4; Suemizu, Hiroshi4; Andoh, Toshiwo

Source: Cancer Science, Volume 98, Number 6, June 2007 , pp. 909-915(7)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

SVS-1/SUSD2 is a novel gene, which inhibits growth and reverses tumorigenic phenotypes of cancer cells in vitro. Here we report identification of a mutant of SVS-1, designated SVS-1-vWDm, in which conserved amino acids GLLG at positions 591-594 in von Willebrand factor type D (vWD) domain are replaced by AAAA. As observed by laser confocal microscope, intracellular localization of the mutant protein has changed such that both the N-terminus and the C-terminus of SVS-1-vWDm were localized in the inner surface of the plasma membrane, whereas the N-terminus of SVS-1 was localized in the outer surface of the plasma membrane. Additionally, SVS-1-vWDm was processed much less efficiently and in a slightly different manner. In in vitro studies, adenovirus-mediated transduction of the SVS-1-vWDmgene induced growth suppression of HeLa cells in a dose-dependent manner, as the wild-type gene and inhibition of anchorage-independent growth. Of great interest is the finding that the mutant protein, vWDm, but not the wild-type one induced apoptosis, as observed by nuclear as well as DNA fragmentation. Activation of caspase-3 and -9, but not caspase-8 or -12, was also demonstrated in vWDm-expressing cells. An inhibition of Akt phosphorylation, a major survival signaling component, also occurred in vWDm-expressing HeLa cells. Together these data suggest that vWDm induces apoptosis by inactivation of survival signaling component Akt and activation of caspase cascade (mitochondrial pathway) in HeLa cells. We propose SVS-1-vWDmas an alternative gene for use in developing new therapeutic strategies for the treatment of cancer. (Cancer Sci 2007; 98: 909-915)

Document Type: Research article

DOI: 10.1111/j.1349-7006.2007.00467.x

Affiliations: 1: Department of Bioinformatics and 2: Department of Environmental Engineering for Symbiosis, Faculty of Engineering, Soka University, Tokyo 192-8577; 3: Department of Surgery and Surgical Oncology, Saitama Medical University, Moroyama-cho, Iruma-gun, Saitama 350-0495; 4: Biomedical Research Department, Central Institute for Experimental Animals, Kawasaki 216-0001, Japan

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A